This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China opposes US secondary tariff push on G7, NATO over Russian oil purchase

( September 15, 2025, 09:16 GMT | Official Statement) -- MLex Summary: China expressed opposition to US demands the G7 and NATO impose 50-100 percent tariffs on Chinese goods because of Beijing's purchases of Russian oil, calling the proposal unilateral bullying and economic coercion. In a statement on Monday, the Ministry of Commerce said China has consistently opposed trade restrictions linked to alleged Russian ties, warning that Washington's push for "secondary tariffs" violates the consensus reached by the two countries' leaders and risks destabilizing global trade and supply chains. China vowed to take all necessary measures to defend its interests if harmed and urged the US to act with caution and resolve disputes through dialogue, while calling on other parties to uphold global trade order and supply-chain security.The statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections